Eli Lilly: A Reminder Why Patience Can Pay With Blue ChipsEli Lilly and CompanyBATS:LLYDukesMarketAnalysis**Primary Uptrend Continues Eli Lilly continues to exhibit a strong long-term uptrend despite experiencing several sizeable corrections along the way. Each major pullback has ultimately been followed by buyers stepping back in and price eventually moving to new highs. **Another All-Time High The latest advance carried price to a new all-time high at $1,249.45. This followed a powerful recovery from the April swing low at $850.51, reinforcing the strength of the broader trend. **$1,100 Support Holding The previous breakout area around $1,100 is now acting as support, with buyers stepping in on recent tests. Holding this zone would keep the latest bullish structure intact and leave the all-time high within reach. **100-Week EMA Remains Important The 100-Week EMA has continued to provide support during deeper corrections within the primary uptrend. Previous pullbacks show that even strong blue-chip stocks can experience significant declines without necessarily damaging their longer-term bullish structure. **Patience Over Chasing Strength With price trading close to historical highs, chasing the latest advance may carry greater risk. The chart provides a reminder that meaningful pullbacks do occur, potentially offering more attractive opportunities for patient investors. **In Summary Eli Lilly is a good example of why patience can pay when following quality blue-chip stocks. Despite several sizeable corrections, the primary trend has continued higher and price recently reached another all-time high. The $1,100 area is now providing initial support, while the 100-Week EMA remains important during deeper pullbacks. With price close to historical highs, waiting for meaningful weakness rather than chasing strength may offer a more favourable risk-to-reward opportunity.